tiprankstipranks
Advertisement
Advertisement

AMGN Stock Latest News

Amgen price target raised to $435 from $400 at Wells Fargo
The FlyAmgen price target raised to $435 from $400 at Wells Fargo
16h ago
AMGN
Amgen price target raised to $435 from $400 at Wells Fargo
PremiumThe Fly
Amgen price target raised to $435 from $400 at Wells Fargo
16h ago
AMGN
Entera is on the Cusp of the Trial That Could Unlock America’s Osteoporosis Drug Market (NASDAQ: ENTX)
PremiumTipRanks Newswire
Entera is on the Cusp of the Trial That Could Unlock America’s Osteoporosis Drug Market (NASDAQ: ENTX)
5d ago
LLY
NVO
Amgen Repatha reduces risk of death in high-risk adults for first heart attack
PremiumThe Fly
Amgen Repatha reduces risk of death in high-risk adults for first heart attack
5d ago
AMGN
Amgen’s Pediatric Psoriasis Study Wrap-Up: What Apremilast Safety Data Means for Investors
PremiumCompany Announcements
Amgen’s Pediatric Psoriasis Study Wrap-Up: What Apremilast Safety Data Means for Investors
7d ago
AMGN
Amgen’s AMG 691 Phase 1 Trial Targets Key Growth in Asian Markets
PremiumCompany AnnouncementsAmgen’s AMG 691 Phase 1 Trial Targets Key Growth in Asian Markets
8d ago
AMGN
Amgen, AstraZeneca announce Crossing trial showed ‘meaningful’ improvements
Premium
The Fly
Amgen, AstraZeneca announce Crossing trial showed ‘meaningful’ improvements
9d ago
AZN
AMGN
AstraZeneca Stock (AZN) Slides Despite New Esophagus Drug Trial Success
Premium
Market News
AstraZeneca Stock (AZN) Slides Despite New Esophagus Drug Trial Success
9d ago
AZN
AMGN
Amgen, AstraZeneca report CROSSING trial met co-primary and secondary endpoints
PremiumThe Fly
Amgen, AstraZeneca report CROSSING trial met co-primary and secondary endpoints
9d ago
AZN
AMGN
Trump Trade: Canada rolls out 50% tariffs on U.S. metals
PremiumThe Fly
Trump Trade: Canada rolls out 50% tariffs on U.S. metals
10d ago
AA
MT
HHS plans to add FDA deputy roles for technology, drugs, CNBC says
PremiumThe Fly
HHS plans to add FDA deputy roles for technology, drugs, CNBC says
10d ago
ABT
BMY
Amgen Extends MariTide Study In Obesity And Diabetes, Keeping Investor Focus On Long-Term Potential
PremiumCompany Announcements
Amgen Extends MariTide Study In Obesity And Diabetes, Keeping Investor Focus On Long-Term Potential
11d ago
AMGN
Amgen Advances Tarlatamab Shot vs. Infusion in Phase 3 Lung Cancer Study
PremiumCompany AnnouncementsAmgen Advances Tarlatamab Shot vs. Infusion in Phase 3 Lung Cancer Study
14d ago
AMGN
Amgen price target raised to $457 from $427 at Piper Sandler
Premium
The Fly
Amgen price target raised to $457 from $427 at Piper Sandler
16d ago
AMGN
Amgen price target raised to $362 from $351 at Morgan Stanley
Premium
The Fly
Amgen price target raised to $362 from $351 at Morgan Stanley
17d ago
AMGN
Amgen price target raised to $460 from $375 at Argus
PremiumThe Fly
Amgen price target raised to $460 from $375 at Argus
17d ago
AMGN
Amgen price target raised to $400 from $350 at Cantor Fitzgerald
PremiumThe Fly
Amgen price target raised to $400 from $350 at Cantor Fitzgerald
18d ago
AMGN
Amgen price target raised to $352 from $303 at Mizuho
PremiumThe Fly
Amgen price target raised to $352 from $303 at Mizuho
18d ago
AMGN
Amgen’s Evolocumab Formulation Study Signals Steady Support for Its Cholesterol Franchise
PremiumCompany Announcements
Amgen’s Evolocumab Formulation Study Signals Steady Support for Its Cholesterol Franchise
18d ago
AMGN
Private Markets: Databricks secures $5B as Kalshi targets $40B valuation
PremiumThe FlyPrivate Markets: Databricks secures $5B as Kalshi targets $40B valuation
19d ago
AI
IBM
Amgen price target raised to $380 from $360 at Barclays
Premium
The Fly
Amgen price target raised to $380 from $360 at Barclays
20d ago
AMGN
The Week That Was, The Week Ahead: Macro and Markets, August 16
Premium
Market News
The Week That Was, The Week Ahead: Macro and Markets, August 16
20d ago
AS
AU

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >